# Flora Gao

> Flora Gao is a Series A investor at Lynx Capital backing Therapeutics and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Lynx Capital](https://shizune.co/investors/profile/lynx-capital-3971)
- Total investments: 1
- Last investment: Mar 2023
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/flora-gao-57524b2b/?original_referer=https%3A%2F%2Fwww%2Egoogle%2Ecom%2F&originalSubdomain=cn

Flora Gao is a Senior Partner of Lynx Financial.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Aurealis Therapeutics | They exist to develop curative solutions that achieve total and faster healing for non-healing wounds and other complex inflammatory diseases with their four-in-one biologic drug, AUP-16. Their goal is to create solid Phase 2 clinical efficacy data in diabetic foot ulcers and non-clinical proof-of-concept data in other inflammatory diseases by endof 2022, and to engage with strategic partners to ensure that this game changing technology benefits millions of patients. | $10M | Series A | Mar 30, 2023 |  |

1 of 1 investments shown.

## Co-investors
- [Tesi](https://shizune.co/investors/profile/tesi) — VC Fund, 1 deal together
- [Zhejiang Huahai Pharmaceutical](https://shizune.co/investors/profile/zhejiang-huahai-pharmaceutical) — VC Fund, 1 deal together

## About Lynx Capital

VC Fund · Shanghai, China

Lynx Capital is a healthcare and life science-focused fund that invests in innovative companies in Western countries in both therapeutics and medical technology, with the possibility of collaborating with Chinese companies to explore the Chinese market.

1 contacts available at Lynx Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Flora Gao | Executive | https://shizune.co/investors/profile/flora-gao |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Flora Gao invest in?

Flora Gao invests primarily in Therapeutics, Biotechnology and Pharmaceutical startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Flora Gao last invest?

The most recent investment recorded for Flora Gao closed in Mar 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co